Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | DGKA | P23743 | 1/20 | 0.41 |
| ▸ | FAAH | O00519 | 4/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | CNR2 | P34972 | 1/20 | 0.30 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28888955 | 0.94 | LMNA (0.52) | LMNAKDM4EDUSP3MEN1KMT2A | |
| SCHEMBL107724 | 0.94 | LMNA (0.52) | LMNAKDM4EDUSP3MEN1KMT2A | |
| Iodide SCHEMBL10812123 | 0.92 | LMNA (0.50) | LMNAKDM4EDUSP3MEN1KMT2A | |
| SCHEMBL16561542 | 0.83 | TSHR (0.42) | LMNAKDM4EDUSP3MEN1KMT2A | |
| SCHEMBL1063274 | 0.79 | LMNA (0.50) | LMNAKDM4EDUSP3MEN1KMT2A | |
| SCHEMBL28001325 | 0.79 | TSHR (0.39) | LMNAKDM4EDUSP3MEN1KMT2A | |
| Glycerin SCHEMBL332069 | 0.78 | LMNA (0.53) | LMNATSHRSLC22A6ALDH1A1OR51E2 | |
| Glycerin SCHEMBL97353 | 0.78 | LMNA (0.53) | LMNATSHRSLC22A6ALDH1A1OR51E2 | |
| Glycerin SCHEMBL560044 | 0.78 | LMNA (0.53) | LMNATSHRSLC22A6ALDH1A1OR51E2 | |
| Glycerin SCHEMBL97662 | 0.78 | LMNA (0.53) | LMNATSHRSLC22A6ALDH1A1OR51E2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 150 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260021142-A1 | HYDROGELS HAVING CONTROLLED HYDROLYTIC DEGRADATION | GEORGIA TECH RES INST (US) | 2026-01-22 | — | — | US | claimed |
| EP-4558545-A1 | HYDROGELS HAVING CONTROLLED HYDROLYTIC DEGRADATION | Georgia Tech Research Corporation (US) | 2025-05-28 | — | — | EP | claimed |
| WO-2024020439-A1 | HYDROGELS HAVING CONTROLLED HYDROLYTIC DEGRADATION | GEORGIA TECH RESEARCH CORPORATION (US) | 2024-01-25 | — | — | WO | claimed |
| EP-3486272-B1 | AROMATIC POLYTHIOL COMPOUND FOR OPTICAL MATERIAL | SKC CO LTD (KR) | 2021-04-28 | — | — | EP | claimed |
| US-20190292144-A1 | AROMATIC POLYTHIOL COMPOUND FOR OPTICAL MATERIAL | SK PUCORE CO., LTD. (KR) | 2019-09-26 | — | — | US | claimed |
| EP-3486272-A1 | AROMATIC POLYTHIOL COMPOUND FOR OPTICAL MATERIAL | SKC Co., Ltd. (KR) | 2019-05-22 | — | — | EP | claimed |
| US-9968558-B2 | Fabrication of hydrogel microsphere delivery vehicles through electrospraying and timed gelation | SAINT LOUIS UNIVERSITY (US) | 2018-05-15 | — | — | US | claimed |
| EP-3230341-A2 | ALIPHATIC POLYCARBONATES AND PRODUCTION METHODS FROM CYCLIC CARBONATES THEREOF | Pyo, Sang-Hyun (SE) | 2017-10-18 | — | — | EP | claimed |
| US-20160271064-A1 | FABRICATION OF HYDROGEL MICROSPHERE DELIVERY VEHICLES THROUGH ELECTROSPRAYING AND TIMED GELATION | SAINT LOUIS UNIVERSITY | 2016-09-22 | — | — | US | claimed |
| US-6225439-B1 | FOR OPTICAL MATERIALS, SUCH AS PLASTIC LENSES, PRISMS, SUBSTRATES OF INFORMATION RECORDING MATERIALS AND FILTERS | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2001-05-01 | — | — | US | claimed |
| US-20260021142-A1 | HYDROGELS HAVING CONTROLLED HYDROLYTIC DEGRADATION | GEORGIA TECH RES INST (US) | 2026-01-22 | — | — | US | disclosed |
| EP-4558545-A1 | HYDROGELS HAVING CONTROLLED HYDROLYTIC DEGRADATION | Georgia Tech Research Corporation (US) | 2025-05-28 | — | — | EP | disclosed |
| US-12287450-B2 | Functional laminate and functional lens comprising the functional laminate | TOKUYAMA CORPORATION (JP) | 2025-04-29 | — | — | US | disclosed |
| EP-4151689-B1 | CURABLE COMPOSITIONS CONTAINING 1,1-DI-ACTIVATED VINYL COMPOUNDS AND RELATED COATINGS AND PROCESSES | PPG IND OHIO INC (US) | 2024-09-04 | — | — | EP | disclosed |
| EP-4169627-B1 | MULTI-LAYER CURABLE COMPOSITIONS CONTAINING 1,1-DI-ACTIVATED VINYL COMPOUND PRODUCTS AND RELATED PROCESSES | PPG IND OHIO INC (US) | 2024-09-04 | — | — | EP | disclosed |
| EP-0936233-A2 | Composition for a resin | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 1999-08-18 | — | — | EP | disclosed |
| EP-0928802-A2 | Process for tinting a resin having a large refractivity index and optical material tinted by the process | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 1999-07-14 | — | — | EP | disclosed |
| EP-0921417-A2 | Epoxy/episulfide resin compositions for optical materials | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 1999-06-09 | — | — | EP | disclosed |
| US-5622926-A | INHIBITING DYE TRANSFER | BASF AKTIENGESELLSCHAFT (DE) | 1997-04-22 | — | — | US | disclosed |
| US-4616046-A | CONTAINING METALLIC HEAT STABILIZER AND CARBOXY MERCAPTAN COMPOUND | ATO CHIMIE (FR) | 1986-10-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190292144-A1 | AROMATIC POLYTHIOL COMPOUND FOR OPTICAL MATERIAL | SMAD3, TCOF1, FGFR3 | LMNA 4042/4885KDM4E 384/4885DUSP3 2740/4885 |
| US-20260021142-A1 | HYDROGELS HAVING CONTROLLED HYDROLYTIC DEGRADATION | KDM8, PTMS, USP2 | LMNA 3725/4885KDM4E 315/4885DUSP3 467/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.